Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated Phase
Clinical trial NCT07383298 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07383298
- Sponsor
- Qian Jiang
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-16
- Primary completion
- 2028-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.